Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04752033 · ClinicalTrials.gov registry record · Phase 4
Intrathecal Opioids for Colorectal Resection
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT04752033: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT04752033 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04752033, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
This research study is being done to determine the optimal dose of spinal morphine and hydromorphone in patients undergoing minimally-invasive (i.e., surgery performed through small entry sites and using cameras) colorectal surgery.
Interventions
- DRUG Hydromorphone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2023-02-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04752033
The ClinicalTrials.gov registry entry for NCT04752033 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT04752033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04752033 about?
NCT04752033 is a clinical study titled "Intrathecal Opioids for Colorectal Resection". This research study is being done to determine the optimal dose of spinal morphine and hydromorphone in patients undergoing minimally-invasive (i.e., surgery performed through small entry sites and using cameras) colorectal surgery.
What is the current status of trial NCT04752033?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-03-10. Estimated completion is 2023-02-17.
What interventions are being tested in trial NCT04752033?
The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT04752033?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.